# "First in Human" - The Potential of Neural Stem Cell-based Approaches for Treatment of Brain Disorders #### calendar\_today Date and Time **December 16, 2014** 12:00PM - 01:00PM EST #### pin\_drop Location **Cell Press Webinar** Register for this free event at: **Guest speakers:** ***Ricardo Dolmetsch*** Global Head of Neuroscience Novartis Institutes for BioMedical Research and Department of Neurobiology, Stanford University ***Kevin Eggan*** Professor, Department of Stem Cell and Regenerative Biology, Harvard University ***Fred Gage*** Professor, Laboratory of Genetics Salk Institute **Moderator:** Angela Messmer-Blust Editor, Conferences, Webinars, and Special Content A key challenge for translational efforts for nervous system disorders has been the development of animal and cellular models that appropriately model disease mechanisms and the complex biology of the human nervous system. With the advances in neurogenetics, we now have long lists of candidate genes for complex disorders such as schizophrenia and autism, but the path from genes to mechanisms has been more challenging. In recent years, new technologies in human-stem-cell-based approaches have come onto the scene as a potential breakthrough to surmount these translational hurdles. In the second of our series of webinars focused on translational neuroscience, we focus on the potential of groundbreaking pluripotent stem cell technologies to model “human” disease pathology and to serve as platforms for drug development. See also:- [ Nervous System Diseases ](/event-disease-area/nervous-system-diseases) - [ Neuropsychiatric Disorders ](/event-disease-area/neuropsychiatric-disorders) - [ Translational Research ](/event-disease-area/translational-research) - [ For the Public ](/event-type/public) Share on:- [ Facebook ](#) - [ Twitter ](#) - [ Linkedin ](#) Save: [ Add to calendar calendar\_today ](https://www.hsci.harvard.edu/node/310131/event-feed.ics) Copy link link